Table 5. Area under the Curve for Cytokines Significantly Different Between Groups in the Pre- and Post-Infection Phase.
| PRE-INFECTION PHASE | |||||||
|---|---|---|---|---|---|---|---|
| Cytokine | Analyses | D14 | D21 | ||||
| BS vs. No Sepsis | FS vs. No Sepsis | BS vs. FS | BS vs. No Sepsis | FS vs. No Sepsis | BS vs. FS | ||
| IL-10 | Unadjusted | 0.56 (0.51-0.60)** | 0.59 (0.51-0.67)** | 0.54 (0.45-0.62)** | 0.61 (0.51-0.72)* | ||
| Adjusted | 0.72 (0.69-0.77) † | 0.81 (0.76-0.86)‡ | 0.80 (0.74-0.86)* | 0.70 (0.61-0.79)* | |||
| IL-18 | Unadjusted | 0.56 (0.52-0.61)* | 0.68 (0.59-0.76)* | ||||
| Adjusted | 0.61 (0.56-0.65)* | ||||||
| TGF-β | Unadjusted | 0.56 (0.51-0.60)* | 0.64 (0.57-0.71)** | 0.67 (0.58-0.77)* | |||
| Adjusted | |||||||
| POST-INFECTION PHASE | |||||||
| Cytokine | Analyses | D14 | D21 | ||||
| BS vs. No Sepsis | FS vs. No Sepsis | BS vs. FS | BS vs. No Sepsis | FS vs. No Sepsis | BS vs. FS | ||
| IL-10 | Unadjusted | 0.73 (0.59-0.87)** | 0.71 (0.56-0.86)* | 0.58 (0.45-0.69)** | |||
| Adjusted | 0.87 (0.76-0.98)** | 0.79 (0.65-0.92)* | 0.85 (0.78-0.91)* | 0.81 (0.73-0.89)** | |||
| IL-18 | Unadjusted | 0.58 (0.51-0.64)* | 0.72 (0.62-0.82)* | 0.59 (0.54-0.64)* | 0.78 (0.72-0.85)‡ | 0.70 (0.61-0.79)** | |
| Adjusted | 0.66 (0.61-0.72)* | 0.61 (0.56-0.66)* | 0.85 (0.79-0.91)** | 0.80 (0.73-0.87)* | |||
| TGF-β | Unadjusted | 0.60 (0.53-0.66)* | 0.79 (0.66-0.92)** | 0.60† | 0.85‡ | 0.78‡ | |
| Adjusted | 0.91 (0.82-1.0)* | 0.63* | 0.92‡ | 0.85† | |||
Numbers represent AUC (95% Confidence Limits)
p<0.05
p<0.01
p<0.001
p<0.0001